|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product revenues | |||||
| Service revenues | |||||
| Total revenues | |||||
| Costs and operating expenses: | |||||
| Cost of revenues | |||||
| Product revenues | |||||
| Service revenues | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Restructuring and other costs | |||||
| Total costs and operating expenses | |||||
| Operating income | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income/(expense) | |||||
| Income before income taxes | |||||
| Benefit from/(provision for) income taxes | |||||
| Equity in earnings/(losses) of unconsolidated entities | |||||
| Net income | |||||
| Less: net income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest | |||||
| Net income attributable to Thermo Fisher Scientific Inc. | |||||
| Earnings per share attributable to Thermo Fisher Scientific Inc. | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...